Latest HOOK reports update at 2024-03-22: 2023 ∙ 2022 ∙ 2021
  1. Home
  2. Stock quotes
  3. HOOKIPA Pharma
  4. Financial Statements
HOOKIPA Pharma logo
HOOKIPA Pharma HOOK
$ 0.8 0.0%
mail-toReport an Error

HOOKIPA Pharma Financial Statements 2011-2024 | HOOK

Annual Financial Statements HOOKIPA Pharma

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

 67.1 M 54.4 M 76.5 M 289 M 226 M - - - - - - - -

Shares

 94.5 M 65.5 M 32.8 M 26 M 17.9 M - - - - - - - -

Historical Prices

 0.71 0.83 2.33 11.1 12.2 - - - - - - - -

Net Income

 -81.6 M -64.9 M -75.7 M -44.1 M -43 M -16.2 M -12.7 M - - - - - -

Revenue

 20.1 M 14.2 M 18.4 M 19.6 M 11.9 M 7.63 M - - - - - - -

Cost of Revenue

 - - - - - - - - - - - - -

Gross Profit

 - - - - - - - - - - - - -

Operating Income

 -97.7 M -73.2 M -81.7 M -53.3 M -51.1 M -21.2 M -14.2 M - - - - - -

Interest Expense

 317 K 687 K 898 K 786 K 877 K 778 K 606 K - - - - - -

EBITDA

 -94.1 M -69.6 M -77 M -49.1 M -42.9 M -14.9 M -11.7 M - - - - - -

Operating Expenses

 - - - - 56.3 M - - - - - - - -

General and Administrative Expenses

 18.6 M 18.8 M 17.3 M 18.1 M 16.7 M 6.84 M 4.38 M - - - - - -

All numbers in USD currency

Quarterly Income Statement HOOKIPA Pharma

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

 110 M 82.7 M 72.2 M - 72.2 M 72.2 M 45 M - 32.9 M 32.8 M 32.8 M - 25.7 M 25.6 M 25.6 M - 25.4 M 19.2 M 1.01 M 1.01 M 912 K 912 K 912 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

 -19.1 M -18 M -19.7 M - -18.3 M -16.4 M -18 M - -20 M -17.2 M -17.2 M -12.5 M -44.1 M -44.1 M -44.1 M -10.2 M -43 M -43 M -43 M -1.89 M -3.95 M -5.82 M -4.57 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

 6.87 M 2.68 M 3.18 M - 2.23 M 2.75 M 1.44 M - 3.87 M 5.38 M 5.3 M 5.16 M 4.04 M 6.68 M 3.7 M 3.62 M 2.04 M 4.05 M 2.24 M 5.08 M 1.9 M 649 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

 -22.7 M -21.5 M -22.7 M - -21 M -18.4 M -20.1 M - -21.2 M -19.3 M -19.2 M - -16.4 M -9.23 M -12.5 M - -13.6 M -13.6 M -10.7 M - -5.55 M -6.98 M -6.45 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

 49 K 97 K 122 K - 105 K 231 K 243 K - 234 K 218 K 219 K - 194 K 166 K 227 K - 227 K 210 K 213 K - 194 K 191 K 193 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

 - - -21.7 M - -18.3 M -16.5 M -19.1 M - -17.8 M -17 M -18.1 M - -13.4 M -7.35 M -11.6 M - -12.5 M -13 M -10.4 M - -5.09 M -6.68 M -6.31 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

 - - - - - - - - - - - 20.4 M 20.4 M 15.9 M 16.2 M 16.8 M 15.6 M 17.7 M 12.9 M 7.28 M 7.45 M 7.62 M 6.45 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

 4.91 M 4.44 M 4.9 M - 4.94 M 5.03 M 4.97 M - 4.34 M 5.1 M 4.31 M - 4.44 M 4.35 M 4.63 M - 4.59 M 3.75 M 2.71 M - 1.28 M 1.41 M 1.48 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency